IHEvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with IHE, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IHE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHE ETF 2 | +1.25%– | +0.82%– | +21.99%– | +39.12%– | +87.20%– | +79.04%– |
| Flows | IHE ETF 2 | -$129M– | +$77M– | +$500M– | +$664M– | +$758M– | +$754M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHE ETF 2 | +18.62%– | +18.66%– | +17.25%– | +16.78%– |
| Max drawdown | IHE ETF 2 | -9.67%– | -9.67%– | -16.04%– | -16.12%– |
| Max drawdown duration | IHE ETF 2 | 65d– | 65d– | 210d– | 669d– |
Trading data
IHE | ETF 2 | |
Last sale 10/23/2026 at 1:30 PM | $102.51 | – |
| Previous close 10/22/2026 | $104.78 | – |
| Consolidated volume 10/22/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
IHE | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/23/2026 at 1:30 PM
Live
Closed
IHE | ETF 2 | |
|---|---|---|
| Last price | $102.51 | – |
| 1D performance | -2.17% | – |
| AuM | $1.54 B | – |
| E/R | 0.37% | – |
Characteristics
IHE | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | iShares | – |
| Benchmark | Dow Jones U.S. Select Pharmaceuticals Index | – |
| N° of holdings | 57 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 1, 2006 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
IHE
USA
95.75%
Other
4.25%
ETF 2
Sectors
IHE
Healthcare
99.75%
Other
0.25%
ETF 2
Advertisement
Diversification
IHE
Total weight of top 15 holdings out of 15
84.42%
ETF 2
–
Top 15 holdings
Data as of August 31, 2026
IHE
Johnson & Johnson
22.45%
Eli Lilly & Co.
20.50%
Merck & Co., Inc.
5.00%
Bristol Myers Squibb Co.
4.84%
Royalty Pharma Plc
4.54%
Pfizer Inc.
4.48%
Viatris, Inc.
4.19%
Zoetis, Inc.
3.82%
Jazz Pharmaceuticals Plc
3.43%
Elanco Animal Health, Inc.
2.61%
Corcept Therapeutics, Inc.
2.36%
Crinetics Pharmaceuticals, Inc.
1.95%
Axsome Therapeutics, Inc.
1.87%
Ligand Pharmaceuticals, Inc.
1.24%
Definium Therapeutics, Inc.
1.12%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about IHE
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
November 20, 2023
IHE
Healthcare Stocks Rebound
August 14, 2023
IHE
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IHE
Advertisement
Advertisement
